Project Grant R43AI191927
Award Date
5/9/25
Completion Date
10/31/25
Dollars Obligated
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Emmune Inc. (N65ZDYUGWAH8)
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Emory University a $653,693 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct research on the structural details of HIV-1 assembly and the mechanism of the capsid targeting compound lenacapavir. The key objectives are to: 1) Develop single particle cryo-electron microscopy techniques to study the immature and mature HIV-1 Gag and capsid lattices, providing insights into the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $176,096 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to the University of Illinois to develop a computational toolkit for dissecting HIV drug resistance mechanisms and designing countermeasures. The project aims to leverage protein conformational dynamics to rigorously quantify how specific residues and interactions contribute to drug resistance, enabling the rational design...
This federal Project Grant award of $107,948 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research aimed at engineering B cells to secrete broadly neutralizing antibodies that could help control HIV in people living with the virus. The key objectives are to: 1) design synthetic protein signaling molecules to enhance B cell function, 2) test the ability of these...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support the development of a novel universal rapid test for HIV diagnosis. IGE Immunodiagnostics & Therapeutics, LLC, a minority-owned small business, will receive $294,948 to adapt their existing HIV ELISA test into a 5th generation antigen/antibody combination rapid test format. The goal is to create a simple, rapid,...
This $220,224 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports computational research on the assembly, maturation, and uncoating processes of the HIV-1 virus. The University of Chicago, the grant recipient, will investigate factors beyond the viral capsid that influence critical morphological transitions in the HIV-1 life cycle, such as the role of host cell factors and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $343,744 to develop a comprehensive product development strategy for an Investigational New Drug (IND) submission. The goal is to facilitate Phase I clinical trials of a novel gene therapy approach using chimeric antigen receptor (CAR)-modified hematopoietic stem/progenitor cells to functionally cure HIV infection. The...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant totaling $742,463 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Washington. This grant, titled "Exploiting Glycan Holes and Sequence Diversity of Naturally Occurring HIV Envelope towards the Design of Vaccine Immunogen Panels for Induction of Neutralization Breadth," aims to leverage bioinformatics, artificial intelligence, and in vitro studies to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $214,613 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Veterans Medical Research Foundation of San Diego. The funding will support a high-risk, high-reward study aimed at identifying the missing protein or pathway that accounts for the HIV-1 Nef protein's ability to enhance viral replication and infectivity in a CD4- and Serinc-independent manner. The research will use...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded $852,121.24 to The Scripps Research Institute-Florida under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period of July 22, 2021 through October 31, 2021. The project aims to identify host factors that regulate HIV latency and reactivation in order to develop strategies for durable HIV silencing. The grantee will define the roles of three identified host factors, P32,...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research on the role of immunoglobulin genetic diversity in the development of neutralizing antibodies against the HIV envelope protein. The $242,310 award to Emory University, spanning from August 2024 to February 2027, aims to identify polymorphisms in rhesus macaques associated with differential development of...